Advertisement
Screener

RAFAEL HOLDINGS, INC. (RFL) Operating Leases, Future Minimum Payments, Due in Two Years

2.8 / 5 stars · 68/120 Roast Me

RAFAEL HOLDINGS, INC. Operating Leases, Future Minimum Payments, Due in Two Years

RAFAEL HOLDINGS, INC. (RFL) had Operating Leases, Future Minimum Payments, Due in Two Years of $666.00 thousand as of 2022-04-30, per its 10-Q filed 2022-06-14.

Discontinued › Notes › Leases

us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears · last filed 2022-06-14

  • 2022-04-30: Operating Leases, Future Minimum Payments, Due in Two Years $666.00K.
  • 2022-01-31: Operating Leases, Future Minimum Payments, Due in Two Years $1.39M.
  • 2021-10-31: Operating Leases, Future Minimum Payments, Due in Two Years $2.19M.
  • 2021-07-31: Operating Leases, Future Minimum Payments, Due in Two Years $2.86M.
Period endOperating Leases, Future Minimum Payments, Due in Two YearsOperating Leases, Future Minimum Payments, Due in Two Years as first filed
2022-04-30$666.00K
10-Q · filed 2022-06-14
2022-01-31$1.39M
10-Q · filed 2022-03-17
2021-10-31$2.19M
10-Q/A · filed 2022-02-28
2021-07-31$2.86M
10-K · filed 2021-10-18
2021-01-31$2.86M
10-Q · filed 2021-03-17
2020-07-31$2.86M
10-Q · filed 2021-06-14
$2.85M
10-K · filed 2020-10-29
2020-04-30$3.15K
10-Q · filed 2020-06-09
2020-01-31$1.60M
10-Q · filed 2020-03-05
2019-10-31$2.42M
10-Q · filed 2019-12-09
2019-07-31$3.18M
10-K · filed 2019-10-04
2019-04-30$3.05M
10-Q · filed 2019-06-05
2019-01-31$3.15M
10-Q · filed 2019-03-12
2018-10-31$3.15M
10-Q · filed 2018-12-10
2018-07-31$3.15M
10-K · filed 2018-10-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
Aditxt, Inc. (ADTX)United States$0.000B
CDT Equity Inc. (CDT)United States$0.000B-0.01
Protagenic Therapeutics, Inc.\new (PTIX)United States$0.001B
Decoy Therapeutics Inc. (DCOY)United States$0.002B-0.27
Nexentis Technologies Inc. (NXTS)$0.002B
ORAGENICS INC (OGEN)United States$0.002B
JUPITER NEUROSCIENCES, INC. (JUNS)United States$0.002B-0.02
BioXcel Therapeutics, Inc. (BTAI)United States$0.002B
ZyVersa Therapeutics, Inc. (ZVSA)United States$0.002B
Matinas BioPharma Holdings, Inc. (MTNB)United States$0.003B